Matthew Cooperberg speaks with Martin Gleave about GUNS, a neoadjuvant adaptive umbrella trial for men with high-volume, high-grade prostate cancer. Now at 280 patients enrolled, GUNS sequences needle ...

Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab, Followed by Adjuvant Pembrolizumab, in Patients with Muscle-Invasive Bladder Cancer (SURE-02): A Single-Arm, Phase 2 Study - Beyond the Abstract ...

Chronic prostatitis/chronic pelvic pain syndrome: Interplay of inflammatory mediators, "Beyond the Abstract," by Dan Lundh, Hans Hedelin, and Dennis Larsson ...

Retroperitoneal Lymphadenectomy (RPLND) for the Treatment of Testicular Germ Cell Tumors-Open or Robotic? pro Open Surgery : RPLND in the Management of Testis Cancer - Beyond the Abstract ...

ASCO 2024 Bladder Cancer ASCO 2024: What Is Variant Histology Urothelial Cancer and What Are the Available Treatment Options? ASCO 2024: Phase II Trial of Intravesical Camrelizumab in BCG-Unresponsive ...

Transdermal Application of H100 Gel to the Penile Shaft in Patients with Peyronie's Disease Infiltrates the Tunica Albuginea - Beyond the Abstract ...

Age 18 and above No gender difference Patients who have been diagnosed with, or are clinically highly suspected of, urothelial carcinomas and have had no other treatment within 3 months ...

ASCO GU 2025 results of a 52-week clinical trial evaluating the safety and tolerability of relugolix in combination with abiraterone or apalutamide, advanced prostate cancer, HERO trial.

(UroToday.com) The 2024 European Association of Urology (EAU) annual meeting featured a game changing session on prime time for adjuvant treatment in locally advanced bladder cancer, and a ...

Amy Pearlman discusses penile rehabilitation strategies following prostate cancer treatment. Dr. Pearlman shares her expertise on vacuum pump therapy as a crucial component of penile rehabilitation.

(UroToday.com) Cisplatin-based neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer (MIBC) can result in pathological complete responses and confers an overall ...

Sam Chang speaks with Vignesh Packiam about the CHAI (Computational Histology AI) biomarker for treatment selection in high-grade non-muscle invasive bladder cancer. This innovative test analyzes ...